Global Adoptive Cell Therapy Market Size, Status and Forecast 2024-2031

Report ID: 920560 | Published Date: Oct 2024 | No. of Page: 108 | Base Year: 2023 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Adoptive Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 CAR-T
        1.2.3 TCR-T
        1.2.4 NK
        1.2.5 TIL
    1.3 Market by Application
        1.3.1 Global Adoptive Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Lymphoma
        1.3.3 Leukemia
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Adoptive Cell Therapy Market Perspective (2016-2027)
    2.2 Adoptive Cell Therapy Growth Trends by Regions
        2.2.1 Adoptive Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Adoptive Cell Therapy Historic Market Share by Regions (2016-2021)
        2.2.3 Adoptive Cell Therapy Forecasted Market Size by Regions (2022-2027)
    2.3 Adoptive Cell Therapy Industry Dynamic
        2.3.1 Adoptive Cell Therapy Market Trends
        2.3.2 Adoptive Cell Therapy Market Drivers
        2.3.3 Adoptive Cell Therapy Market Challenges
        2.3.4 Adoptive Cell Therapy Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Adoptive Cell Therapy Players by Revenue
        3.1.1 Global Top Adoptive Cell Therapy Players by Revenue (2016-2021)
        3.1.2 Global Adoptive Cell Therapy Revenue Market Share by Players (2016-2021)
    3.2 Global Adoptive Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Adoptive Cell Therapy Revenue
    3.4 Global Adoptive Cell Therapy Market Concentration Ratio
        3.4.1 Global Adoptive Cell Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cell Therapy Revenue in 2020
    3.5 Adoptive Cell Therapy Key Players Head office and Area Served
    3.6 Key Players Adoptive Cell Therapy Product Solution and Service
    3.7 Date of Enter into Adoptive Cell Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Adoptive Cell Therapy Breakdown Data by Type
    4.1 Global Adoptive Cell Therapy Historic Market Size by Type (2016-2021)
    4.2 Global Adoptive Cell Therapy Forecasted Market Size by Type (2022-2027)

5 Adoptive Cell Therapy Breakdown Data by Application
    5.1 Global Adoptive Cell Therapy Historic Market Size by Application (2016-2021)
    5.2 Global Adoptive Cell Therapy Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Adoptive Cell Therapy Market Size (2016-2027)
    6.2 North America Adoptive Cell Therapy Market Size by Type
        6.2.1 North America Adoptive Cell Therapy Market Size by Type (2016-2021)
        6.2.2 North America Adoptive Cell Therapy Market Size by Type (2022-2027)
        6.2.3 North America Adoptive Cell Therapy Market Size by Type (2016-2027)
    6.3 North America Adoptive Cell Therapy Market Size by Application
        6.3.1 North America Adoptive Cell Therapy Market Size by Application (2016-2021)
        6.3.2 North America Adoptive Cell Therapy Market Size by Application (2022-2027)
        6.3.3 North America Adoptive Cell Therapy Market Size by Application (2016-2027)
    6.4 North America Adoptive Cell Therapy Market Size by Country
        6.4.1 North America Adoptive Cell Therapy Market Size by Country (2016-2021)
        6.4.2 North America Adoptive Cell Therapy Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Adoptive Cell Therapy Market Size (2016-2027)
    7.2 Europe Adoptive Cell Therapy Market Size by Type
        7.2.1 Europe Adoptive Cell Therapy Market Size by Type (2016-2021)
        7.2.2 Europe Adoptive Cell Therapy Market Size by Type (2022-2027)
        7.2.3 Europe Adoptive Cell Therapy Market Size by Type (2016-2027)
    7.3 Europe Adoptive Cell Therapy Market Size by Application
        7.3.1 Europe Adoptive Cell Therapy Market Size by Application (2016-2021)
        7.3.2 Europe Adoptive Cell Therapy Market Size by Application (2022-2027)
        7.3.3 Europe Adoptive Cell Therapy Market Size by Application (2016-2027)
    7.4 Europe Adoptive Cell Therapy Market Size by Country
        7.4.1 Europe Adoptive Cell Therapy Market Size by Country (2016-2021)
        7.4.2 Europe Adoptive Cell Therapy Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Adoptive Cell Therapy Market Size (2016-2027)
    8.2 Asia-Pacific Adoptive Cell Therapy Market Size by Type
        8.2.1 Asia-Pacific Adoptive Cell Therapy Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Adoptive Cell Therapy Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Adoptive Cell Therapy Market Size by Type (2016-2027)
    8.3 Asia-Pacific Adoptive Cell Therapy Market Size by Application
        8.3.1 Asia-Pacific Adoptive Cell Therapy Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Adoptive Cell Therapy Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Adoptive Cell Therapy Market Size by Application (2016-2027)
    8.4 Asia-Pacific Adoptive Cell Therapy Market Size by Region
        8.4.1 Asia-Pacific Adoptive Cell Therapy Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Adoptive Cell Therapy Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Adoptive Cell Therapy Market Size (2016-2027)
    9.2 Latin America Adoptive Cell Therapy Market Size by Type
        9.2.1 Latin America Adoptive Cell Therapy Market Size by Type (2016-2021)
        9.2.2 Latin America Adoptive Cell Therapy Market Size by Type (2022-2027)
        9.2.3 Latin America Adoptive Cell Therapy Market Size by Type (2016-2027)
    9.3 Latin America Adoptive Cell Therapy Market Size by Application
        9.3.1 Latin America Adoptive Cell Therapy Market Size by Application (2016-2021)
        9.3.2 Latin America Adoptive Cell Therapy Market Size by Application (2022-2027)
        9.3.3 Latin America Adoptive Cell Therapy Market Size by Application (2016-2027)
    9.4 Latin America Adoptive Cell Therapy Market Size by Country
        9.4.1 Latin America Adoptive Cell Therapy Market Size by Country (2016-2021)
        9.4.2 Latin America Adoptive Cell Therapy Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Adoptive Cell Therapy Market Size (2016-2027)
    10.2 Middle East & Africa Adoptive Cell Therapy Market Size by Type
        10.2.1 Middle East & Africa Adoptive Cell Therapy Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Adoptive Cell Therapy Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Adoptive Cell Therapy Market Size by Type (2016-2027)
    10.3 Middle East & Africa Adoptive Cell Therapy Market Size by Application
        10.3.1 Middle East & Africa Adoptive Cell Therapy Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Adoptive Cell Therapy Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Adoptive Cell Therapy Market Size by Application (2016-2027)
    10.4 Middle East & Africa Adoptive Cell Therapy Market Size by Country
        10.4.1 Middle East & Africa Adoptive Cell Therapy Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Adoptive Cell Therapy Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Novartis
        11.1.1 Novartis Company Details
        11.1.2 Novartis Business Overview
        11.1.3 Novartis Adoptive Cell Therapy Introduction
        11.1.4 Novartis Revenue in Adoptive Cell Therapy Business (2016-2021)
        11.1.5 Novartis Recent Development
    11.2 Juno
        11.2.1 Juno Company Details
        11.2.2 Juno Business Overview
        11.2.3 Juno Adoptive Cell Therapy Introduction
        11.2.4 Juno Revenue in Adoptive Cell Therapy Business (2016-2021)
        11.2.5 Juno Recent Development
    11.3 Kite
        11.3.1 Kite Company Details
        11.3.2 Kite Business Overview
        11.3.3 Kite Adoptive Cell Therapy Introduction
        11.3.4 Kite Revenue in Adoptive Cell Therapy Business (2016-2021)
        11.3.5 Kite Recent Development
    11.4 Adaptimmune
        11.4.1 Adaptimmune Company Details
        11.4.2 Adaptimmune Business Overview
        11.4.3 Adaptimmune Adoptive Cell Therapy Introduction
        11.4.4 Adaptimmune Revenue in Adoptive Cell Therapy Business (2016-2021)
        11.4.5 Adaptimmune Recent Development
    11.5 Fibrocell
        11.5.1 Fibrocell Company Details
        11.5.2 Fibrocell Business Overview
        11.5.3 Fibrocell Adoptive Cell Therapy Introduction
        11.5.4 Fibrocell Revenue in Adoptive Cell Therapy Business (2016-2021)
        11.5.5 Fibrocell Recent Development
    11.6 Lineage Cell Therapeutics
        11.6.1 Lineage Cell Therapeutics Company Details
        11.6.2 Lineage Cell Therapeutics Business Overview
        11.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Introduction
        11.6.4 Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2016-2021)
        11.6.5 Lineage Cell Therapeutics Recent Development
    11.7 BioTime
        11.7.1 BioTime Company Details
        11.7.2 BioTime Business Overview
        11.7.3 BioTime Adoptive Cell Therapy Introduction
        11.7.4 BioTime Revenue in Adoptive Cell Therapy Business (2016-2021)
        11.7.5 BioTime Recent Development
    11.8 Vericel Corporation
        11.8.1 Vericel Corporation Company Details
        11.8.2 Vericel Corporation Business Overview
        11.8.3 Vericel Corporation Adoptive Cell Therapy Introduction
        11.8.4 Vericel Corporation Revenue in Adoptive Cell Therapy Business (2016-2021)
        11.8.5 Vericel Corporation Recent Development
    11.9 Regeneus
        11.9.1 Regeneus Company Details
        11.9.2 Regeneus Business Overview
        11.9.3 Regeneus Adoptive Cell Therapy Introduction
        11.9.4 Regeneus Revenue in Adoptive Cell Therapy Business (2016-2021)
        11.9.5 Regeneus Recent Development
    11.10 Anhui Anke Biotechnology
        11.10.1 Anhui Anke Biotechnology Company Details
        11.10.2 Anhui Anke Biotechnology Business Overview
        11.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Introduction
        11.10.4 Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2016-2021)
        11.10.5 Anhui Anke Biotechnology Recent Development
    11.11 Cellectis
        11.11.1 Cellectis Company Details
        11.11.2 Cellectis Business Overview
        11.11.3 Cellectis Adoptive Cell Therapy Introduction
        11.11.4 Cellectis Revenue in Adoptive Cell Therapy Business (2016-2021)
        11.11.5 Cellectis Recent Development
    11.12 NantKwest
        11.12.1 NantKwest Company Details
        11.12.2 NantKwest Business Overview
        11.12.3 NantKwest Adoptive Cell Therapy Introduction
        11.12.4 NantKwest Revenue in Adoptive Cell Therapy Business (2016-2021)
        11.12.5 NantKwest Recent Development
    11.13 SorrentoTherapeutics
        11.13.1 SorrentoTherapeutics Company Details
        11.13.2 SorrentoTherapeutics Business Overview
        11.13.3 SorrentoTherapeutics Adoptive Cell Therapy Introduction
        11.13.4 SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2016-2021)
        11.13.5 SorrentoTherapeutics Recent Development
    11.14 Bellicum
        11.14.1 Bellicum Company Details
        11.14.2 Bellicum Business Overview
        11.14.3 Bellicum Adoptive Cell Therapy Introduction
        11.14.4 Bellicum Revenue in Adoptive Cell Therapy Business (2016-2021)
        11.14.5 Bellicum Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Adoptive Cell Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of CAR-T
    Table 3. Key Players of TCR-T
    Table 4. Key Players of NK
    Table 5. Key Players of TIL
    Table 6. Global Adoptive Cell Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Adoptive Cell Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Adoptive Cell Therapy Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Adoptive Cell Therapy Market Share by Regions (2016-2021)
    Table 10. Global Adoptive Cell Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Adoptive Cell Therapy Market Share by Regions (2022-2027)
    Table 12. Adoptive Cell Therapy Market Trends
    Table 13. Adoptive Cell Therapy Market Drivers
    Table 14. Adoptive Cell Therapy Market Challenges
    Table 15. Adoptive Cell Therapy Market Restraints
    Table 16. Global Adoptive Cell Therapy Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Adoptive Cell Therapy Market Share by Players (2016-2021)
    Table 18. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adoptive Cell Therapy as of 2020)
    Table 19. Ranking of Global Top Adoptive Cell Therapy Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Adoptive Cell Therapy Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Adoptive Cell Therapy Product Solution and Service
    Table 23. Date of Enter into Adoptive Cell Therapy Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Adoptive Cell Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Adoptive Cell Therapy Revenue Market Share by Type (2016-2021)
    Table 27. Global Adoptive Cell Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Adoptive Cell Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Adoptive Cell Therapy Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Adoptive Cell Therapy Revenue Market Share by Application (2016-2021)
    Table 31. Global Adoptive Cell Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Adoptive Cell Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Adoptive Cell Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Adoptive Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Adoptive Cell Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Adoptive Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Adoptive Cell Therapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Adoptive Cell Therapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Adoptive Cell Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Adoptive Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Adoptive Cell Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Adoptive Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Adoptive Cell Therapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Adoptive Cell Therapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Adoptive Cell Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Adoptive Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Adoptive Cell Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Adoptive Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Adoptive Cell Therapy Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Adoptive Cell Therapy Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Adoptive Cell Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Adoptive Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Adoptive Cell Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Adoptive Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Adoptive Cell Therapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Adoptive Cell Therapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Adoptive Cell Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Adoptive Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Adoptive Cell Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Adoptive Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Adoptive Cell Therapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Adoptive Cell Therapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Novartis Company Details
    Table 64. Novartis Business Overview
    Table 65. Novartis Adoptive Cell Therapy Product
    Table 66. Novartis Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
    Table 67. Novartis Recent Development
    Table 68. Juno Company Details
    Table 69. Juno Business Overview
    Table 70. Juno Adoptive Cell Therapy Product
    Table 71. Juno Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
    Table 72. Juno Recent Development
    Table 73. Kite Company Details
    Table 74. Kite Business Overview
    Table 75. Kite Adoptive Cell Therapy Product
    Table 76. Kite Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
    Table 77. Kite Recent Development
    Table 78. Adaptimmune Company Details
    Table 79. Adaptimmune Business Overview
    Table 80. Adaptimmune Adoptive Cell Therapy Product
    Table 81. Adaptimmune Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
    Table 82. Adaptimmune Recent Development
    Table 83. Fibrocell Company Details
    Table 84. Fibrocell Business Overview
    Table 85. Fibrocell Adoptive Cell Therapy Product
    Table 86. Fibrocell Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
    Table 87. Fibrocell Recent Development
    Table 88. Lineage Cell Therapeutics Company Details
    Table 89. Lineage Cell Therapeutics Business Overview
    Table 90. Lineage Cell Therapeutics Adoptive Cell Therapy Product
    Table 91. Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
    Table 92. Lineage Cell Therapeutics Recent Development
    Table 93. BioTime Company Details
    Table 94. BioTime Business Overview
    Table 95. BioTime Adoptive Cell Therapy Product
    Table 96. BioTime Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
    Table 97. BioTime Recent Development
    Table 98. Vericel Corporation Company Details
    Table 99. Vericel Corporation Business Overview
    Table 100. Vericel Corporation Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
    Table 101. Vericel Corporation Recent Development
    Table 102. Regeneus Company Details
    Table 103. Regeneus Business Overview
    Table 104. Regeneus Adoptive Cell Therapy Product
    Table 105. Regeneus Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
    Table 106. Regeneus Recent Development
    Table 107. Anhui Anke Biotechnology Company Details
    Table 108. Anhui Anke Biotechnology Business Overview
    Table 109. Anhui Anke Biotechnology Adoptive Cell Therapy Product
    Table 110. Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
    Table 111. Anhui Anke Biotechnology Recent Development
    Table 112. Cellectis Company Details
    Table 113. Cellectis Business Overview
    Table 114. Cellectis Adoptive Cell Therapy Product
    Table 115. Cellectis Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
    Table 116. Cellectis Recent Development
    Table 117. NantKwest Company Details
    Table 118. NantKwest Business Overview
    Table 119. NantKwest Adoptive Cell Therapy Product
    Table 120. NantKwest Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
    Table 121. NantKwest Recent Development
    Table 122. SorrentoTherapeutics Company Details
    Table 123. SorrentoTherapeutics Business Overview
    Table 124. SorrentoTherapeutics Adoptive Cell Therapy Product
    Table 125. SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
    Table 126. SorrentoTherapeutics Recent Development
    Table 127. Bellicum Company Details
    Table 128. Bellicum Business Overview
    Table 129. Bellicum Adoptive Cell Therapy Product
    Table 130. Bellicum Revenue in Adoptive Cell Therapy Business (2016-2021) & (US$ Million)
    Table 131. Bellicum Recent Development
    Table 132. Research Programs/Design for This Report
    Table 133. Key Data Information from Secondary Sources
    Table 134. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Adoptive Cell Therapy Market Share by Type: 2020 VS 2027
    Figure 2. CAR-T Features
    Figure 3. TCR-T Features
    Figure 4. NK Features
    Figure 5. TIL Features
    Figure 6. Global Adoptive Cell Therapy Market Share by Application: 2020 VS 2027
    Figure 7. Lymphoma Case Studies
    Figure 8. Leukemia Case Studies
    Figure 9. Adoptive Cell Therapy Report Years Considered
    Figure 10. Global Adoptive Cell Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Adoptive Cell Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Adoptive Cell Therapy Market Share by Regions: 2020 VS 2027
    Figure 13. Global Adoptive Cell Therapy Market Share by Regions (2022-2027)
    Figure 14. Global Adoptive Cell Therapy Market Share by Players in 2020
    Figure 15. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adoptive Cell Therapy as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Adoptive Cell Therapy Revenue in 2020
    Figure 17. Global Adoptive Cell Therapy Revenue Market Share by Type (2016-2021)
    Figure 18. Global Adoptive Cell Therapy Revenue Market Share by Type (2022-2027)
    Figure 19. North America Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Adoptive Cell Therapy Market Share by Type (2016-2027)
    Figure 21. North America Adoptive Cell Therapy Market Share by Application (2016-2027)
    Figure 22. North America Adoptive Cell Therapy Market Share by Country (2016-2027)
    Figure 23. United States Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Adoptive Cell Therapy Market Share by Type (2016-2027)
    Figure 27. Europe Adoptive Cell Therapy Market Share by Application (2016-2027)
    Figure 28. Europe Adoptive Cell Therapy Market Share by Country (2016-2027)
    Figure 29. Germany Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Adoptive Cell Therapy Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Adoptive Cell Therapy Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Adoptive Cell Therapy Market Share by Region (2016-2027)
    Figure 39. China Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Adoptive Cell Therapy Market Share by Type (2016-2027)
    Figure 47. Latin America Adoptive Cell Therapy Market Share by Application (2016-2027)
    Figure 48. Latin America Adoptive Cell Therapy Market Share by Country (2016-2027)
    Figure 49. Mexico Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Adoptive Cell Therapy Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Adoptive Cell Therapy Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Adoptive Cell Therapy Market Share by Country (2016-2027)
    Figure 55. Turkey Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Adoptive Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Novartis Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
    Figure 59. Juno Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
    Figure 60. Kite Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
    Figure 61. Adaptimmune Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
    Figure 62. Fibrocell Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
    Figure 63. Lineage Cell Therapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
    Figure 64. BioTime Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
    Figure 65. Vericel Corporation Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
    Figure 66. Regeneus Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
    Figure 67. Anhui Anke Biotechnology Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
    Figure 68. Cellectis Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
    Figure 69. NantKwest Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
    Figure 70. SorrentoTherapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
    Figure 71. Bellicum Revenue Growth Rate in Adoptive Cell Therapy Business (2016-2021)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
Juno
Kite
Adaptimmune
Fibrocell
Lineage Cell Therapeutics
BioTime
Vericel Corporation
Regeneus
Anhui Anke Biotechnology
Cellectis
NantKwest
SorrentoTherapeutics
Bellicum
Frequently Asked Questions
Adoptive Cell Therapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Adoptive Cell Therapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Adoptive Cell Therapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

eSIM Technology

An eSIM is exactly what it sounds like: An electronic, or embedded, SIM. Instead of a physical  ... Read More